Bell's palsy

Last reviewed: 7 Sep 2022
Last updated: 07 Jun 2022

Summary

Definition

History and exam

Key diagnostic factors

  • single episode
  • unilateral
  • absence of constitutional symptoms
  • involvement of all nerve branches
  • keratoconjunctivitis sicca
  • pain
  • synkinesis
More key diagnostic factors

Other diagnostic factors

  • any age
  • hyperacusis
  • dysgeusia
Other diagnostic factors

Risk factors

  • intranasal influenza vaccination
  • pregnancy
  • upper respiratory tract infection
  • arid/cold climate
  • hypertension
  • family history of Bell's palsy
  • diabetes
  • dental procedures
More risk factors

Diagnostic investigations

1st investigations to order

  • clinical diagnosis
  • electroneuronography (ENoG) (evoked electromyography - eEMG)
  • needle electromyography (EMG)
  • serology for Borrelia burgdorferi
More 1st investigations to order

Investigations to consider

  • pure-tone audiometry
  • tympanometry and stapedius reflex
  • MRI (gadolinium-enhanced fine-cut of facial nerve course)
  • CT (fine-cut, non-enhanced)
More investigations to consider

Treatment algorithm

ACUTE

all patients

Contributors

Authors

Matthew Q. Miller, MD

Assistant Professor Otolaryngology-Head and Neck Surgery

Director UNC Facial Nerve Center

University of North Carolina-Chapel Hill

Chapel Hill

NC

Disclosures

MQM declares that he has no competing interests.

Liliana Ein, MD

Assistant Professor Otolaryngology-Head and Neck Surgery

Division of Facial Plastic and Reconstructive Surgery

University of Miami

Miami

FL

Disclosures

LE declares that she has no competing interests.

Acknowledgements

Dr Matthew Q. Miller and Dr Liliana Ein would like to gratefully acknowledge Dr Tessa Hadlock, Dr Nathan Jowett, Dr Vishnu Madhok, Dr Iain Swan, Dr Pauline Lockhart, Dr Michael Norbury, and Dr John Gail Neely, previous contributors to this topic.

Disclosures

TH, VM, IS, PL, MN, and JGN declare that they have no competing interests. NJ holds a patent on the methods and systems for functional electrical stimulation of the paralyzed face (WO2017124019A1).

Peer reviewers

Giles Elrington, MBBS (Hons), MD, FRCP

Consultant Neurologist

Barts Health NHS Trust

London

UK

Disclosures

GE is involved in a number of clinical trials on multiple sclerosis sponsored by Genzyme, Roche, Teva, Novartis, Biogen, as well as one funded by the MRC. He is also involved in clinical trials sponsored by Allergan, NMT Medical, GlaxoSmithKline (GSK), Bristol-Myers, the UK's Parkinson's Disease Research Group, and Pharmacia. In addition, he has attended lectures, conferences and symposia with the following companies - GSK, Astra Zeneca, MSD, Almirall, Pfizer, Menarini, Allergan, Biogen, Teva, Conference Plus, Infomed, BMJ.

Patrick Grogan, MD

Major

US Air Force

MC Program Director

Department of Neurology

MMCN

Wilford Hall Medical Center

Lackland Air Force Base

TX

Disclosures

PG declares that he has no competing interests.

Venkat Srinivasan, MBBS, DLO, FRCS (Ed), FRCS (ORL)

Consultant in ENT/Thyroid Surgery

Arrowe Park Hospital

Upton

Wirral

UK

Disclosures

VS declares that he has no competing interests.

  • Differentials

    • Herpes zoster oticus (Ramsay Hunt syndrome)
    • Lyme disease
    • Benign facial nerve tumor (e.g., facial nerve schwannoma)
    More Differentials
  • Guidelines

    • ACR appropriateness criteria: cranial neuropathy
    • Facial palsy (Bell's palsy)
    More Guidelines
  • Patient leaflets

    Bell palsy

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer